Structure-based computational design of antibody mimetics: challenges and perspectives

被引:2
|
作者
Chaves, Elton J. F. [1 ]
Coelho, Danilo F. [2 ]
Cruz, Carlos H. B. [3 ]
Moreira, Emerson G. [4 ]
Simoes, Julio C. M. [1 ,2 ]
Nascimento-Filho, Manasses J. [1 ,2 ]
Lins, Roberto D. [1 ,2 ,4 ]
机构
[1] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, Brazil
[2] Univ Fed Pernambuco, Dept Fundamental Chem, Recife, Brazil
[3] UCL, Inst Struct & Mol Biol, London, England
[4] Fiocruz Genom Network, Rio De Janeiro, Brazil
来源
FEBS OPEN BIO | 2025年 / 15卷 / 02期
关键词
de novo design; deep learning; machine learning; protein engineering; protein structure; ARMADILLO REPEAT PROTEINS; HIGH-AFFINITY; BINDING-PROTEINS; OPTIMIZATION; PREDICTION; DYNAMICS; MONOBODIES; SCAFFOLD;
D O I
10.1002/2211-5463.13855
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The design of antibody mimetics holds great promise for revolutionizing therapeutic interventions by offering alternatives to conventional antibody therapies. Structure-based computational approaches have emerged as indispensable tools in the rational design of those molecules, enabling the precise manipulation of their structural and functional properties. This review covers the main classes of designed antigen-binding motifs, as well as alternative strategies to develop tailored ones. We discuss the intricacies of different computational protein-protein interaction design strategies, showcased by selected successful cases in the literature. Subsequently, we explore the latest advancements in the computational techniques including the integration of machine and deep learning methodologies into the design framework, which has led to an augmented design pipeline. Finally, we verse onto the current challenges that stand in the way between high-throughput computer design of antibody mimetics and experimental realization, offering a forward-looking perspective into the field and the promises it holds to biotechnology.
引用
收藏
页码:223 / 235
页数:13
相关论文
共 50 条
  • [31] Structure-based design
    Charlotte Harrison
    Nature Reviews Drug Discovery, 2011, 10 : 658 - 658
  • [32] Structure-based design
    Harrison, Charlotte
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (09) : 658 - 658
  • [33] Structure-based integrative computational and experimental approach for the optimization of drug design
    Morikis, D
    Floudas, CA
    Lambris, JD
    COMPUTATIONAL SCIENCE - ICCS 2005, PT 2, 2005, 3515 : 680 - 688
  • [34] Novel computational pipelines in antiviral structure-based drug design (Review)
    Diakou, Io
    Papakonstantinou, Eleni
    Papageorgiou, Louis
    Pierouli, Katerina
    Dragoumani, Konstantina
    Spandidos, Demetrios A.
    Bacopoulou, Flora
    Chrousos, George P.
    Eliopoulos, Elias
    Vlachakis, Dimitrios
    BIOMEDICAL REPORTS, 2022, 17 (06)
  • [35] Structure-based mutagenesis of Penicillium griseofulvum xylanase using computational design
    Andre-Leroux, Gwenaelle
    Berrin, Jean-Guy
    Georis, Jacques
    Arnaut, Filip
    Juge, Nathalie
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 72 (04) : 1298 - 1307
  • [36] Structure-Based Prediction of Protease Multispecificity using Computational Protein Design
    Khare, Sagar D.
    Rubenstein, Aliza
    Pethe, Manasi
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 345A - 345A
  • [37] Structure-Based Drug Design: Synergy of Structural Biology and Computational Methods
    Frye, Leah L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : A209 - A209
  • [38] Advances in Computational Structure-Based Drug Design and Application in Drug Discovery
    Wang, Tao
    Wu, Mian-Bin
    Zhang, Ri-Hao
    Chen, Zheng-Jie
    Hua, Chen
    Lin, Jian-Ping
    Yang, Li-Rong
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (09) : 901 - 916
  • [39] Structure-based approaches to inhibition of erbB receptors with peptide mimetics
    Berezov, A
    Greene, MI
    Murali, R
    IMMUNOLOGIC RESEARCH, 2003, 27 (2-3) : 303 - 308
  • [40] Structure-based approaches to inhibition of erbB receptors with peptide mimetics
    Alan Berezov
    Mark I. Greene
    Ramachandran Murali
    Immunologic Research, 2003, 27 : 303 - 308